If approved, etelcalcetide will be the first calcimimetic agent that can be administered intravenously. Amgen executive vice president of research and development Sean Harper said: "We’re pleased that
The investigational drug SM04690 is a small molecule inhibitor of the Wnt pathway. The approximately 400 patient trial will study three different doses of SM04690 against a placebo,
The study, which appears in the journal ACS Nano, shows how the nanoparticle system targets the precise cells infected by the bacteria and maximizes the amount of drug
ARKRAY USA president Jonathan Chapman said: "We are pleased that Medi-Cal will make ARKRAY’s line of blood glucose meters, testing strips and ancillary supplies available to their members
This innovative funding approach, into a cancer with low survival rates and in urgent need of better treatments, will support over 24 researchers across the UK and US
Launched in India in 1980, Little’s is present across a wide range of products including – baby feeding bottles, baby skin-care, baby grooming accessories, baby apparels and baby
This action follows the earlier inspections of these sites by the agency in November 2014, January 2015 and February 2015, respectively. Dr. Reddy’s CEO G V Prasad said:
Additionally, Agenus obtained an exclusive license to a phage display library from IONTAS, and entered into an agreement for cell line development technology with Selexis. These new capabilities,
MD Anderson will leverage its expertise in developing allogeneic umbilical cord blood and peripheral blood derived NK-cell therapies and combine it with CytomX’s Probody technology to address new
Both companies have worked very closely to launch a new solution that takes advantage of the 16 years of pioneering experience Planbox has in the Innovation Management and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.